Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi

Fabian Cataldo(Dignitas International), Sam Phiri(Lighthouse Trust), Mina C. Hosseinipour, Florence Kasende(Dignitas International), Misheck J. Nkhata(Dignitas International), Frank Chimbwandira(Ministry of Health), Erik J Schouten(African Institute for Development Policy), Levison Chiwaula(University of Malawi), Monique van Lettow(University of Toronto), Hannock Tweya(University of Washington), Atupele Kapito–Tembo(University of Malawi), Nora E. Rosenberg, Veena Sampathkumar(Christian Health Association of Malawi), Michael Eliya(Ministry of Health)

JAIDS Journal of Acquired Immune Deficiency Syndromes

December 31, 2016

10.1097/qai.0000000000001273

Cited by 66

Related Papers

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi

|AIDS|2014|375

Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach

|The Lancet|2011|237

Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study

|The Lancet HIV|2016|177

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

|PLoS Medicine|2018|171

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

|The Lancet HIV|2020|171